case_images: PMC11754420_01
case_images: Comparison of changes in nasopharyngeal, neck and liver contrast-enhanced MRI, EBV-DNA before and after treatment in patient 1. (A) Comparison of nasopharyngeal contrast-enhanced MRI changes in patient 1 before and after treatment. (B, C) Comparison of neck contrast-enhanced MRI changes in patient 1 before and after treatment. (D) Comparison of liver contrast-enhanced MRI changes in patient 1 before and after treatment. (E) Longitudinal EBV-DNA titer before and after treatment of disease. The unit of EBV DNA levels was copies/mL. EBV, Epstein-Barr virus.
case_images: fimmu-15-1467355-g001.jpg
case_images: PMC11754420_01_fimmu-15-1467355-g001.jpg
case_images: f1
case_images: The level of EBV DNA was consistently below the minimum detection limit ( Figure 1 ).
case_images: PMC11754420_02
case_images: Comparison of changes in nasopharyngeal, neck and liver contrast-enhanced MRI, EBV-DNA before and after treatment in patient 2. (A) Comparison of nasopharyngeal contrast-enhanced MRI changes in patient 2 before and after treatment. (B) Comparison of neck contrast-enhanced MRI changes in patient 2 before and after treatment. (C) Comparison of liver contrast-enhanced MRI changes in patient 2 before and after treatment. (D) Longitudinal EBV-DNA titer before and after treatment of disease. The unit of EBV DNA levels was copies/mL. EBV, Epstein-Barr virus.
case_images: fimmu-15-1467355-g002.jpg
case_images: PMC11754420_02_fimmu-15-1467355-g002.jpg
case_images: f2
case_images: The level of EBV DNA was consistently below the minimum detection limit ( Figure 2 ).